In quiet debut, Alzheimer’s drug finds questions, skepticism

New Zealand dispenses record number of jabs at ‘Vaxathon’
16 October 2021
Study: Serotonin stabilizes social memories
18 October 2021

In quiet debut, Alzheimer’s drug finds questions, skepticism

The first new Alzheimer’s treatment in more than 20 years was hailed as a breakthrough when regulators approved it more than four months ago, but its rollout has been slowed by questions about its price and how well it works.

Comments are closed.